Ascendis Pharma - 53 Year Dividend History | ASND
Historical dividend payout and yield for Ascendis Pharma (ASND) since 1971. The current TTM dividend payout for Ascendis Pharma (ASND) as of November 19, 2024 is $0.00. The current dividend yield for Ascendis Pharma as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$7.546B |
$0.288B |
|
Ascendis Pharma A/S is a biopharmaceutical company. The company's product pipeline consist of TransCon Human Growth Hormone, TransCon Treprostinil, TransCon Insulin, TransCon Peptide and TransCon Ranibizumab, which are in different clinical stage, for the treatments of hormone deficiency, endocrinology, central nervous system disorders, infectious diseases and diabetes. Its technology includes TransCon which develop prodrug therapies. Ascendis Pharma A/S is based in Denmark.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
